Table 2.
Patient characteristics.
| Variable | Inpatients (n = 30) | Outpatients (n = 50) | P |
|---|---|---|---|
| Gender (male : female) | 23 : 7 | 44 : 6 | 0.22 |
| Age in years (mean ± SD) | 49.63 ± 10.17 | 47.68 ± 7.91 | 0.34 |
| Height in meters (mean ± SD) | 1.67 ± 0.08 | 1.67 ± 0.06 | 0.81 |
| Body weight in kg (mean ± SD) | 68.00 ± 13.90 | 68.52 ± 12.53 | 0.86 |
| BMI in kg/m2 (mean ± SD) | 24.34 ± 4.38 | 24.45 ± 4.22 | 0.91 |
| TNM stage (AJCC, 2009); n | 0.91 | ||
| Stage I | 2 | 5 | |
| Stage II | 6 | 8 | |
| Stage III | 8 | 12 | |
| Stage IV | 14 | 25 | |
| Tumor location (n) | 0.75 | ||
| NPC | 15 | 22 | |
| Oral cavity | 7 | 17 | |
| Pharynx | 7 | 10 | |
| Others | 1 | 1 | |
| Modes of treatment (n) | 0.35 | ||
| Surgery + radiotherapy + chemotherapy | 6 | 15 | |
| Radiotherapy + chemotherapy | 20 | 32 | |
| Surgery + radiotherapy | 2 | 2 | |
| Radiotherapy | 2 | 1 | |
| Dose of radiotherapy in Gray (mean ± SD) | 70.47 ± 3.44 | 69.20 ± 2.14 | 0.045a |
AJCC, American Joint Committee on Cancer; NPC, nasopharyngeal carcinoma; BMI, body mass index.
Age, height, body weight, BMI, and dose are presented as means ± standard deviation.
Significant difference between the 2 groups was found only for dose of radiotherapy (inpatients > outpatients, P = 0.045).
a P < 0.05.